INVO FERTILITY INC (IVF) Stock Price, Forecast & Analysis
USA - NASDAQ:IVF - US44984F7087 - Common Stock
IVF Key Statistics, Chart & Performance
The current stock price of IVF is 0.5406 USD. In the past month the price decreased by -31.66%.
IVF Latest News, Press Relases and Analysis
IVF Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.77 | 215.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.05 | 191.53B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.14 | 149.24B | ||
| SYK | STRYKER CORP | 27.05 | 136.19B | ||
| MDT | MEDTRONIC PLC | 16.4 | 116.34B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 51.22B | ||
| IDXX | IDEXX LABORATORIES INC | 52.42 | 50.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.08 | 48.41B | ||
| RMD | RESMED INC | 24.94 | 36.03B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.22B | ||
| DXCM | DEXCOM INC | 31.3 | 22.83B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.46 | 26.31B |
Related stock screener links
About IVF
Company Profile
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Company Info
INVO FERTILITY INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 28
Phone: 19788789505
INVO FERTILITY INC / IVF FAQ
What does INVO FERTILITY INC do?
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Can you provide the latest stock price for INVO FERTILITY INC?
The current stock price of IVF is 0.5406 USD. The price increased by 17.24% in the last trading session.
Does INVO FERTILITY INC pay dividends?
IVF does not pay a dividend.
What is the ChartMill technical and fundamental rating of IVF stock?
IVF has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for INVO FERTILITY INC?
INVO FERTILITY INC (IVF) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is INVO FERTILITY INC worth?
INVO FERTILITY INC (IVF) has a market capitalization of 2.36M USD. This makes IVF a Nano Cap stock.
Can you provide the short interest for IVF stock?
The outstanding short interest for INVO FERTILITY INC (IVF) is 0.88% of its float.
IVF Technical Analysis
IVF Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IVF. IVF may be in some trouble as it scores bad on both profitability and health.
IVF Financial Highlights
Over the last trailing twelve months IVF reported a non-GAAP Earnings per Share(EPS) of -81.07. The EPS decreased by -734.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.93% | ||
| ROE | -1071.38% | ||
| Debt/Equity | 0.73 |
IVF Forecast & Estimates
5 analysts have analysed IVF and the average price target is 18.36 USD. This implies a price increase of 3296.23% is expected in the next year compared to the current price of 0.5406.
For the next year, analysts expect an EPS growth of 92.84% and a revenue growth 10.02% for IVF